Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Deborah J. Wexler MD, MSc Associate Editor

Richard E. Pratley MD Associate Editor

See All Experts

featured

Published in Diabetes and

Journal Scan / Research · March 28, 2023

SGLT2 Inhibitors and Cancer Outcomes

Diabetes Research and Clinical Practice

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Edoardo Mannucci MD

Diabetes Research and Clinical Practice

Sodium-Glucose Cotransporter-2 inhibitors and Cancer Outcomes: a systematic review and meta-analysis of randomized controlled trials

Diabetes Res. Clin. Pract. 2023 Mar 13;[EPub Ahead of Print], BF Spiazzi, RA Naibo, LF Wayerbacher, GF Piccoli, LP Farenzena, TM Londero, GR da Natividade, M Zoldan, N A H Degobi, M Niches, G Lopes, EJ Boyko, KM Utzschneider, V Colpani, F Gerchman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Obesity, Metabolic Syndrome, and Prediabetes

SGLT2 Inhibitors and Cancer Outcomes

Additional Info

Sodium-Glucose Cotransporter-2 inhibitors and Cancer Outcomes: a systematic review and meta-analysis of randomized controlled trials

Further Reading

Higher Fibre and Lower Carbohydrate Intake Are Associated With Favourable CGM Metrics in Type 1 Diabetes

Outcomes of Time-Restricted Eating in Adults With Metabolic Syndrome

Impact of Hypoglycaemia on Daily Functioning in Adults With Diabetes Using the Hypo-METRICS App

Coronary Artery Disease Risk Prediction by Combined Stratification of Low-Density and High-Density Lipoprotein Cholesterol Levels Across Different Glucose Statuses

Automating Insulin Delivery Through Pump and Continuous Glucose Monitoring Connectivity: Maximizing Opportunities to Improve Outcomes

Prognostic Value of Visceral and Subcutaneous Adiposity for Cardiovascular Disease

Role of Ambulatory Blood Pressure Monitoring in Predicting the Risk of Vascular Complications in Type 1 Diabetes

Perinatal Outcomes Associated With Metformin Use During Pregnancy in Women With Pregestational Type 2 Diabetes

Glycaemic and Weight Effects of Metabolic Surgery vs Semaglutide in Patients With Type 2 Diabetes

Impact of an Advanced Hybrid Closed-Loop System on Glycemic Control Throughout the Menstrual Cycle in Women With Type 1 Diabetes Prone to Hypoglycemia

Beta-Hydroxybutyrate Levels and the Risk of Diabetic Ketoacidosis in Adults With Type 1 Diabetes Treated With Sotagliflozin

Recently Updated